Sexually Transmitted Infections (STIs)
Oncology·MeSH: Chemsex
Prevalence
14320.8 / 100K
Incidence
4984.9 / 100K/yr
1 drug in development·1 company·4 clinical trials
Drug Pipeline by Phase
Unknown(1)
| Drug | Company |
|---|---|
| Ainos Flora (VOC POCT) | Ainos Inc. (AIMD) |
Frequently asked questions
How many drugs are in development for Sexually Transmitted Infections (STIs)?
BioSniper tracks 1 drug in development for Sexually Transmitted Infections (STIs) across 1 company.
How many clinical trials target Sexually Transmitted Infections (STIs)?
There are 4 clinical trials targeting Sexually Transmitted Infections (STIs) tracked by BioSniper.
What is the prevalence of Sexually Transmitted Infections (STIs)?
The estimated prevalence of Sexually Transmitted Infections (STIs) is approximately 14320.8 per 100,000 population.
Deep-dive into Sexually Transmitted Infections (STIs)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis